Log in to save to my catalogue

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovat...

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2779350596

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

About this item

Full title

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

Publisher

New York: Springer US

Journal title

Pharmaceutical research, 2023-07, Vol.40 (7), p.1601-1631

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Long-acting injectable (LAI) formulations can provide several advantages over the more traditional oral formulation as drug product opportunities. LAI formulations can achieve sustained drug release for extended periods of time, which results in less frequent dosing requirements leading to higher patient adherence and more optimal therapeutic outco...

Alternative Titles

Full title

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2779350596

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2779350596

Other Identifiers

ISSN

0724-8741,1573-904X

E-ISSN

1573-904X

DOI

10.1007/s11095-022-03391-y

How to access this item